Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuren Pharmaceuticals Limited ( (AU:NEU) ) has provided an announcement.
Neuren Pharmaceuticals Limited has announced that State Street Corporation and its subsidiaries have become substantial holders in the company as of May 1, 2025. This development indicates a significant investment and interest from State Street, potentially impacting Neuren Pharmaceuticals’ market positioning and shareholder dynamics.
More about Neuren Pharmaceuticals Limited
YTD Price Performance: 3.11%
Average Trading Volume: 1,218
Technical Sentiment Signal: Sell
Current Market Cap: $1.03B
For an in-depth examination of NEU stock, go to TipRanks’ Stock Analysis page.